title: Glucocorticoid regulates secretion of epidermal growth factor in the human salivary gland adenocarcinoma cell line.
abstract: The treatment of a human submandibular gland adenocarcinoma cell line (HSG cell line) for 48 h with triamcinolone acetonide (TA; 1-100 nmol/l) reduced the secretion of epidermal growth factor (EGF) in a closely related manner to a maximum of 66%. The reduction in the level of EGF secreted resulted in the suppression of DNA synthesis in the HSG cells to a similar extent. When the cells were incubated with TA and exogenous human EGF (hEGF), DNA synthesis was 1.7-fold higher than that without added hEGF. The removal of EGF by the addition of hEGF antibody reduced DNA synthesis in HSG cell cultures to the same extent as did TA. These results suggest that the growth inhibition of HSG cells by TA is due to the reduction in the amount of EGF secreted.
authors.affiliation: Department of Biochemistry, Iwate Medical University School of Dentistry, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Kurokawa
authors.forename: S
authors.initials: S
authors.lastname: Kyakumoto
authors.forename: M
authors.initials: M
authors.lastname: Ota
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism*; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D012468:Salivary Gland Neoplasms / Q000378:metabolism*; D013365:Submandibular Gland Neoplasms / Q000378:metabolism*; D014222:Triamcinolone Acetonide / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
chemical_list: D004273:DNA, Neoplasm; D004815:Epidermal Growth Factor; D014222:Triamcinolone Acetonide